Ronnie Poon

Articles in Scholarly Journals [Incomplete List]

  1. Tumor Size and Operative Risks of Extended Right-Sided Hepatic Resection for Hepatocellular Carcinoma: Implication for Preoperative Portal Vein Embolization
    Archives of Surgery, vol. 142, no. 1, pp. 63–69, 2007
  2. Induction of long-term liver allograft survival by delayed immunosuppression is dependent on interleukin-10
    Liver Transplantation, vol. 13, no. 4, pp. 571–578, 2007
  3. Antiinflammatory properties of IL-10 rescue small-for-size liver grafts
    Liver Transplantation, vol. 13, no. 4, pp. 558–565, 2007
  4. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma
    Cancer Letters, vol. 248, no. 1, pp. 32–40, 2007
  5. Clinical significance of serum angiocidin levels in hepatocellular carcinoma?
    Cancer Letters, vol. 251, no. 1, pp. 28–35, 2007
  6. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence
    British Journal of Cancer, vol. 97, no. 1, Article ID 6603827, 7 pages, 2007
  7. Pin1 Interacts With a Specific Serine-Proline Motif of Hepatitis B Virus X-Protein to Enhance Hepatocarcinogenesis
    Gastroenterology, vol. 132, no. 3, pp. 1088–1103, 2007
  8. Recent advances and controversies in surgical management of liver diseases: Summary of Liver Sessions of 7th World Congress of IHPBA 2006
    HPB, vol. 9, no. 2, pp. 83–86, 2007
  9. Current techniques of liver transection
    HPB, vol. 9, no. 3, pp. 166–173, 2007
  10. Difference in Tumor Invasiveness in Cirrhotic Patients With Hepatocellular Carcinoma Fulfilling the Milan Criteria Treated by Resection and Transplantation
    Annals of Surgery, vol. 245, no. 1, pp. 51–58, 2007
  11. A Randomized, Controlled Trial of Postoperative Adjuvant Interferon Therapy After Resection of Hepatocellular Carcinoma
    Annals of Surgery, vol. 245, no. 6, pp. 831–842, 2007
  12. Optimal Initial Treatment for Early Hepatocellular Carcinoma in Patients with Preserved Liver Function: Transplantation or Resection?
    Annals of Surgical Oncology, vol. 14, no. 2, pp. 541–547, 2007
  13. High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies
    Annals of Surgical Oncology, vol. 14, no. 6, pp. 1835–1845, 2007
  14. Twist Overexpression Correlates with Hepatocellular Carcinoma Metastasis through Induction of Epithelial-Mesenchymal Transition
    Clinical Cancer Research, vol. 12, no. 18, pp. 5369–5376, 2006
  15. Rac Activation Is Associated with Hepatocellular Carcinoma Metastasis by Up-regulation of Vascular Endothelial Growth Factor Expression
    Clinical Cancer Research, vol. 12, no. 17, pp. 5082–5089, 2006
  16. Regulation of Angiogenesis by Id-1 through Hypoxia-Inducible Factor-1 -Mediated Vascular Endothelial Growth Factor Up-regulation in Hepatocellular Carcinoma
    Clinical Cancer Research, vol. 12, no. 23, pp. 6910–6919, 2006
  17. Liver Intestine-Cadherin (CDH17) Haplotype Is Associated with Increased Risk of Hepatocellular Carcinoma
    Clinical Cancer Research, vol. 12, no. 17, pp. 5248–5252, 2006
  18. Signal Transducers and Activators of Transcription 5b Activation Enhances Hepatocellular Carcinoma Aggressiveness through Induction of Epithelial-Mesenchymal Transition
    Cancer Research, vol. 66, no. 20, pp. 9948–9956, 2006
  19. High doses of tyrosine kinase inhibitor PTK787 enhance the efficacy of ischemic hypoxia for the treatment of hepatocellular carcinoma: dual effects on cancer cell and angiogenesis
    Molecular Cancer Therapeutics, vol. 5, no. 9, pp. 2261–2270, 2006
  20. Natural History of Patients with Recurrent Chronic Hepatitis C Virus and Occult Hepatitis B Co-Infection after Liver Transplantation.
    American Journal of Transplantation, vol. 6, no. 7, pp. 1600–1608, 2006
  21. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma
    British Journal of Cancer, vol. 95, no. 8, Article ID 6603399, 5 pages, 2006
  22. Platelet activation during tumor development, the potential role of BDNFâ??TrkB autocrine loopâ??
    Biochemical and Biophysical Research Communications, vol. 346, no. 3, pp. 981–985, 2006
  23. Suppression of hypoxia inducible factor-1a (HIF-1a) by YC-1 is dependent on murine double minute 2 (Mdm2)?
    Biochemical and Biophysical Research Communications, vol. 348, no. 4, pp. 1443–1448, 2006
  24. Molecular pathways in hepatocellular carcinoma
    Cancer Letters, vol. 240, no. 2, pp. 157–169, 2006
  25. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
    Cancer Letters, vol. 242, no. 2, pp. 151–167, 2006
  26. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma
    Journal of Hepatology, vol. 45, no. 4, pp. 553–559, 2006
  27. Therapeutic Potential of Cardiotrophin 1 in Fulminant Hepatic Failure: Dual Roles in Antiapoptosis and Cell Repair
    Archives of Surgery, vol. 141, no. 11, pp. 1077–1084, 2006
  28. Comparable Survival in Patients With Unresectable Hepatocellular Carcinoma Treated by Radiofrequency Ablation or Transarterial Chemoembolization
    Archives of Surgery, vol. 141, no. 12, pp. 1231–1236, 2006
  29. Safety Limit of Large-Volume Hepatic Radiofrequency Ablation in a Rat Model
    Archives of Surgery, vol. 141, no. 3, pp. 252–258, 2006
  30. Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion
    British Journal of Surgery, vol. 93, no. 4, pp. 440–447, 2006
  31. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma
    Hepatology, vol. 44, no. 4, pp. 836–843, 2006
  32. Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma
    International Journal of Cancer, vol. 118, no. 6, pp. 1527–1538, 2006
  33. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: A comparative study
    Journal of Surgical Oncology, vol. 94, no. 7, pp. 565–571, 2006
  34. PIN1 expression contributes to hepatic carcinogenesis
    The Journal of Pathology, vol. 210, no. 1, pp. 19–25, 2006
  35. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma
    The Journal of Pathology, vol. 210, no. 4, pp. 459–468, 2006
  36. Clinical implications of angiogenesis in cancers
    Vascular Health and Risk Management, vol. 2, no. 2, pp. 97–108, 2006
  37. Is Hepatic Resection for Large or Multinodular Hepatocellular Carcinoma Justified? Results From a Multi-Institutional Database
    Annals of Surgical Oncology, vol. 12, no. 5, pp. 364–373, 2005
  38. Staging of hepatocellular carcinoma
    Hepatology, vol. 42, no. 3, pp. 738–739, 2005
  39. Critical Appraisal of the Clinical and Pathologic Predictors of Survival After Resection of Large Hepatocellular Carcinoma
    Archives of Surgery, vol. 140, no. 5, pp. 450–458, 2005
  40. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study
    Surgery, vol. 137, no. 4, pp. 403–410, 2005
  41. Radiofrequency ablation for malignant liver tumor
    Surgical Oncology, vol. 14, no. 1, pp. 41–52, 2005
  42. The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma
    Biomedecine & Pharmacotherapy, vol. 59, pp. S311–S316, 2005
  43. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
    Liver Transplantation, vol. 11, no. 9, pp. 1086–1092, 2005
  44. Chemokine receptors support infiltration of lymphocyte subpopulations in human hepatocellular carcinoma
    Clinical Immunology, vol. 114, no. 2, pp. 174–182, 2005
  45. Assessment of hepatic reserve for indication of hepatic resection: how I do it
    Journal of Hepato-Biliary-Pancreatic Surgery, vol. 12, no. 1, pp. 31–37, 2005
  46. Selective Portal Vein Clamping for Radiofrequency Ablation of Hepatocellular Carcinoma With Portal Vein Invasion
    Journal of Gastrointestinal Surgery, vol. 9, no. 4, pp. 489–493, 2005
  47. Liver resection using a saline-linked radiofrequency dissecting sealer for transection of the liver
    Journal of the American College of Surgeons, vol. 200, no. 2, pp. 308–313, 2005
  48. Comparison of Early Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Management of Acute Biliary Pancreatitis: A Prospective Randomized Study
    Clinical Gastroenterology and Hepatology, vol. 3, no. 12, pp. 1238–1244, 2005
  49. Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages
    International Immunology, vol. 17, no. 11, pp. 1391–1397, 2005
  50. Better Survival in Female Patients With Hepatocellular Carcinoma
    Journal of Clinical Gastroenterology, vol. 39, no. 6, pp. 533–539, 2005
  51. Role of minimally invasive surgery for hepatobiliary malignancies
    Surgical Practice, vol. 9, no. 3, pp. 75–77, 2005
  52. Role of radiofrequency ablation for liver malignancies
    Surgical Practice, vol. 9, no. 3, pp. 94–103, 2005
  53. Porcine Liver: Morphologic Characteristics and Cell Viability at Experimental Radiofrequency Ablation with Internally Cooled Electrodes
    Radiology, vol. 235, no. 2, pp. 478–486, 2005
  54. Both Antiangiogenesis- and Angiogenesis-Independent Effects Are Responsible for Hepatocellular Carcinoma Growth Arrest by Tyrosine Kinase Inhibitor PTK787/ZK222584
    Cancer Research, vol. 65, no. 9, pp. 3691–3699, 2005
  55. Clinico-biochemical prediction of biliary cause of acute pancreatitis in the era of endoscopic ultrasonography
    Alimentary Pharmacology and Therapeutics, vol. 22, no. 5, pp. 423–431, 2005
  56. Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma
    Molecular Cancer Therapeutics, vol. 4, no. 9, pp. 1430–1438, 2005
  57. FTY720: A Promising Agent for Treatment of Metastatic Hepatocellular Carcinoma
    Clinical Cancer Research, vol. 11, no. 23, pp. 8458–8466, 2005
  58. Radiofrequency Ablation for Subcapsular Hepatocellular Carcinoma
    Annals of Surgical Oncology, vol. 11, no. 3, pp. 281–289, 2004
  59. Comparison of Systemic Responses of Radiofrequency Ablation, Cryotherapy, and Surgical Resection in a Porcine Liver Model
    Annals of Surgical Oncology, vol. 11, no. 7, pp. 650–657, 2004
  60. Clinical Significance of Thrombospondin 1 Expression in Hepatocellular Carcinoma
    Clinical Cancer Research, vol. 10, no. 12, pp. 4150–4157, 2004
  61. Reduced Expression of Chemokine Receptors on Peripheral Blood Lymphocytes in Patients with Hepatocellular Carcinoma
    The American Journal of Gastroenterology, vol. 99, no. 6, pp. 1111–1121, 2004
  62. Outcomes of Patients with Hepatocellular Carcinoma Presenting with Variceal Bleeding
    The American Journal of Gastroenterology, vol. 99, no. 11, pp. 2158–2165, 2004
  63. Prognostic Impact of Diabetes Mellitus on Patients with Hepatocellular Carcinoma
    The American Journal of Gastroenterology, vol. 99, no. 8, pp. 1488–1489, 2004
  64. Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening
    Alimentary Pharmacology and Therapeutics, vol. 19, no. 7, pp. 771–777, 2004
  65. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial
    Alimentary Pharmacology and Therapeutics, vol. 19, no. 7, pp. 779–788, 2004
  66. The Potential Role of Hypoxia Inducible Factor 1  in Tumor Progression after Hypoxia and Chemotherapy in Hepatocellular Carcinoma
    Cancer Research, vol. 64, no. 15, pp. 5496–5503, 2004
  67. Abdominal Drainage After Hepatic Resection Is Contraindicated in Patients With Chronic Liver Diseases
    Annals of Surgery, vol. 239, no. 2, pp. 194–201, 2004
  68. Learning Curve for Radiofrequency Ablation of Liver Tumors
    Annals of Surgery, vol. 239, no. 4, pp. 441–449, 2004
  69. Improving Perioperative Outcome Expands the Role of Hepatectomy in Management of Benign and Malignant Hepatobiliary Diseases
    Transactions of the ... Meeting of the American Surgical Association, vol. CXXII, no. &NA;, pp. 296–308, 2004
  70. Is Primary Resection and Salvage Transplantation for Hepatocellular Carcinoma a Reasonable Strategy?
    Annals of Surgery, vol. 240, no. 5, pp. 925–928, 2004
  71. PIN1 overexpression and ß-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma
    Oncogene, vol. 23, no. 23, Article ID 1207493, 4 pages, 2004
  72. Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target
    Carcinogenesis, vol. 26, no. 3, pp. 681–687, 2004
  73. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18
    European Journal of Cancer, vol. 40, no. 16, pp. 2439–2444, 2004
  74. Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
    Journal of Gastrointestinal Surgery, vol. 8, no. 7, pp. 794–805, 2004
  75. Impact of Preoperative Fine-needle Aspiration Cytologic Examination on Clinical Outcome in Patients With Hepatocellular Carcinoma in a Tertiary Referral Center
    Archives of Surgery, vol. 139, no. 2, pp. 193–200, 2004
  76. Effectiveness of Radiofrequency Ablation for Hepatocellular Carcinomas Larger Than 3 cm in Diameter
    Archives of Surgery, vol. 139, no. 3, pp. 281–287, 2004
  77. Impact of radiofrequency ablation on the management of patients with hepatocellular carcinoma in a specialized centre
    British Journal of Surgery, vol. 91, no. 3, pp. 334–338, 2004
  78. Influence of laparoscopy on postoperative recurrence and survival in patients with ruptured hepatocellular carcinoma undergoing hepatic resection
    British Journal of Surgery, vol. 91, no. 4, pp. 444–449, 2004
  79. Delayed portal vein thrombosis after experimental radiofrequency ablation near the main portal vein
    British Journal of Surgery, vol. 91, no. 5, pp. 632–639, 2004
  80. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma
    British Journal of Surgery, vol. 91, no. 10, pp. 1354–1360, 2004
  81. Critical evaluation of the different staging systems for hepatocellular carcinoma(Br J Surg 2004; 91: 400-408)
    British Journal of Surgery, vol. 91, no. 8, pp. 1072–1072, 2004
  82. Hepatectomy for hepatocellular carcinoma: Patient selection and postoperative outcome
    Liver Transplantation, vol. 10, no. S2, pp. S39–S45, 2004
  83. Management of hepatocellular carcinoma in renal transplant recipients
    Journal of Surgical Oncology, vol. 87, no. 3, pp. 139–142, 2004
  84. Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma
    International Journal of Cancer, vol. 107, no. 1, pp. 22–29, 2003
  85. Perioperative and Long-term Outcome of Major Hepatic Resection for Small Solitary Hepatocellular Carcinoma in Patients With Cirrhosis
    Archives of Surgery, vol. 138, no. 11, pp. 1207–1213, 2003
  86. Value of Live Donor Liver Transplantation Experience in Major Hepatectomy for Hepatocellular Carcinoma
    Archives of Surgery, vol. 138, no. 3, pp. 265–271, 2003
  87. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma
    British Journal of Surgery, vol. 90, no. 1, pp. 33–41, 2003
  88. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma
    British Journal of Surgery, vol. 90, no. 3, pp. 325–331, 2003
  89. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis
    The Journal of Pathology, vol. 199, no. 3, pp. 345–353, 2003
  90. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients
    Surgical Oncology Clinics of North America, vol. 12, no. 1, pp. 35–50, 2003
  91. Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway
    Carcinogenesis, vol. 24, no. 11, pp. 1729–1736, 2003
  92. Thoracoabdominal approach for right-sided hepatic resection for hepatocellular carcinoma1
    Journal of the American College of Surgeons, vol. 196, no. 3, pp. 418–427, 2003
  93. Thermal ablative therapy for malignant liver tumors: A critical appraisal
    Journal of Gastroenterology and Hepatology, vol. 18, no. 6, pp. 616–629, 2003
  94. Annals of Surgery, vol. 237, no. 3, pp. 376–383, 2003
  95. Annals of Surgery, vol. 238, no. 1, pp. 9–28, 2003
  96. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial
    Gut, vol. 52, no. 12, pp. 1768–1773, 2003
  97. Long-Term Disease-Free Survival After Resection of Hepatocellular Carcinoma: Both Tumor Behavior and Surgeon?s Performance Are Important Determinants
    Annals of Surgical Oncology, vol. 10, no. 8, pp. 834–836, 2003
  98. Clinicopathologic and Prognostic Significance of the Histologic Activity of Noncancerous Liver Tissue in Hepatitis B Virus-Associated Hepatocellular Carcinoma
    American Journal of Clinical Pathology, vol. 117, no. 3, pp. 411–418, 2002
  99. Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepatocellular Carcinoma: A Prospective Study
    Journal of Clinical Oncology, vol. 20, no. 7, pp. 1775–1785, 2002
  100. Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function
    Annals of Surgery, vol. 235, no. 3, pp. 373–382, 2002
  101. Annals of Surgery, vol. 235, no. 4, pp. 466–486, 2002
  102. Annals of Surgery, vol. 236, no. 5, pp. 602–611, 2002
  103. Annals of Surgery, vol. 236, no. 6, pp. 738–749, 2002
  104. Annals of Surgery, vol. 236, no. 6, pp. 768–776, 2002
  105. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
    Hepatology, vol. 35, no. 5, pp. 1164–1171, 2002
  106. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma
    Hepatology, vol. 36, no. 3, pp. 687–691, 2002
  107. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter1
    Journal of the American College of Surgeons, vol. 194, no. 5, pp. 592–602, 2002
  108. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy
    Journal of the American College of Surgeons, vol. 195, no. 3, pp. 311–318, 2002
  109. Clinical implications of altered energy metabolism in patients with cirrhosis
    Nutrition, vol. 18, no. 3, pp. 283–284, 2002
  110. Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy
    The American Journal of Surgery, vol. 183, no. 1, pp. 42–52, 2002
  111. Intraoperative Iatrogenic Rupture of Hepatocellular Carcinoma
    World Journal of Surgery, vol. 26, no. 3, pp. 348–352, 2002
  112. Choledochal Cysts in Adults
    Archives of Surgery, vol. 137, no. 4, pp. 465–468, 2002
  113. Management of Gallstone Cholangitis in the Era of Laparoscopic Cholecystectomy
    Archives of Surgery, vol. 136, no. 1, pp. 11–16, 2001
  114. A Prospective Longitudinal Study of Quality of Life After Resection of Hepatocellular Carcinoma
    Archives of Surgery, vol. 136, no. 6, pp. 693–699, 2001
  115. Emergency surgery for obstructing colorectal cancers: a comparison between right-sided and left-sided lesions
    Journal of the American College of Surgeons, vol. 192, no. 6, pp. 719–725, 2001
  116. Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma
    The American Journal of Surgery, vol. 182, no. 3, pp. 298–304, 2001
  117. Detection of choledocholithiasis by EUS in acute pancreatitis: A prospective evaluation in 100 consecutive patients
    Gastrointestinal Endoscopy, vol. 54, no. 3, pp. 325–330, 2001
  118. Annals of Surgery, vol. 233, no. 2, pp. 227–235, 2001
  119. Annals of Surgery, vol. 234, no. 1, pp. 63–70, 2001
  120. Microvessel Density, Vascular Endothelial Growth Factor and Its Receptors Flt-1 and Flk-1/KDR in Hepatocellular Carcinoma
    American Journal of Clinical Pathology, vol. 116, no. 6, pp. 838–845, 2001
  121. Annals of Surgery, vol. 231, no. 4, pp. 544–551, 2000
  122. Annals of Surgery, vol. 232, no. 1, pp. 10–24, 2000
  123. Annals of Surgery, vol. 232, no. 1, pp. 25–31, 2000
  124. Massive GI bleeding due to a duodenal arteriovenous malformation
    Gastrointestinal Endoscopy, vol. 52, no. 1, pp. 101–104, 2000
  125. EUS for detection of occult cholelithiasis in patients with idiopathic pancreatitis
    Gastrointestinal Endoscopy, vol. 51, no. 1, pp. 28–32, 2000
  126. GI hemorrhage from fistula between right hepatic artery pseudoaneurysm and the duodenum secondary to acute cholecystitis
    Gastrointestinal Endoscopy, vol. 51, no. 4, pp. 491–493, 2000
  127. Perioperative nutritional support in liver surgery
    Nutrition, vol. 16, no. 1, pp. 75–76, 2000
  128. Determining resectability for hepatocellular carcinoma: the role of laparoscopy and laparoscopic ultrasonography
    Journal of Hepato-Biliary-Pancreatic Surgery, vol. 7, no. 3, pp. 260–264, 2000
  129. Angiogenesis in Hepatocellular Carcinoma
    Asian Journal of Surgery, vol. 23, no. 3, p. 259, 2000
  130. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence
    Journal of Surgical Oncology, vol. 73, no. 2, pp. 109–114, 2000
  131. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma
    Cancer, vol. 89, no. 3, pp. 500–507, 2000
  132. Hepatectomy for Hepatocellular Carcinoma: The Surgeon's Role in Long-term Survival
    Archives of Surgery, vol. 134, no. 10, pp. 1124–1130, 1999
  133. Prospective Evaluation of Selective Defunctioning Stoma for Low Anterior Resection with Total Mesorectal Excision
    World Journal of Surgery, vol. 23, no. 5, pp. 463–468, 1999
  134. Inflammatory Cecal Masses in Patients Presenting with Appendicitis
    World Journal of Surgery, vol. 23, no. 7, pp. 713–716, 1999
  135. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial???
    Gastrointestinal Endoscopy, vol. 49, no. 5, pp. 593–598, 1999
  136. Annals of Surgery, vol. 229, no. 2, pp. 216–222, 1999
  137. Risk factors for rebleeding and death from peptic ulcer in the very elderly
    British Journal of Surgery, vol. 85, no. 1, pp. 121–124, 1998
  138. Emergency resection and primary anastomosis for left-sided obstructing colorectal carcinoma in the elderly
    British Journal of Surgery, vol. 85, no. 11, pp. 1539–1542, 1998
  139. Annals of Surgery, vol. 227, no. 3, pp. 357–364, 1998
  140. Multiple Primary Cancers in Esophageal Squamous Cell Carcinoma: Incidence and Implications
    The Annals of Thoracic Surgery, vol. 65, no. 6, pp. 1529–1534, 1998
  141. Quality of Life in Patients With Cancer of the Esophagus and Gastric Cardia: A Case for Palliative Resection
    Archives of Surgery, vol. 133, no. 3, pp. 316–322, 1998
  142. Repeated hepatectomies for recurrent follicular dendritic cell tumour of liver: a case report
    European Journal of Surgical Oncology, vol. 23, no. 6, pp. 572–574, 1997